Neurological imaging: new FRW molecule able to bind to blood vessels

Written by Olivia Stevenson (Future Science Group)

Researchers have developed FRW, a peptide that can bind to blood vessels without binding to other organs; this could lead to novel imaging techniques for neurodegenerative diseases. Researchers from the University of São Paolo (São Paolo, Brazil), have developed a molecule known as FRW, that when injected into the bloodstream was able to bind to blood vessels in the brain and no other organs, producing the first complete map of the vasculature of the brain. This could possibly lead to novel methods of diagnostic imaging. Currently, the development of novel drugs with the ability to bind to blood vessels in...

To view this content, please register now for access

It's completely free